Global Cancer Drug Spending Hit The $100 Billion Mark In 2014 ...
Bidness ETC-3 hours ago
Earlier this year, the largest pharmacy-benefit manager in the US, managed to draw out steep discounts on hepatitis C drugs from Gilead Sciences, Inc.
IMS Health Report Shows Global Spending For Cancer Drugs Now ...
Tech Times-4 hours ago
Tech Times-4 hours ago
Explore in depth (48 more articles)
No comments:
Post a Comment